Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds
The use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to a study published in the Nov. 16 issue ...
Nov 16, 2023
0
0